Artiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3eBEuwA
via IFTTT